Farallon Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44.7M | Buy |
+226,499
| New | +$43.7M | 0.29% | 43 |
|
|
2024
Q3 | – | Sell |
-1,204,859
| Closed | -$188M | – | 167 |
|
|
2024
Q2 | $188M | Buy |
1,204,859
+475,000
| +65% | +$71.5M | 1.11% | 38 |
|
|
2024
Q1 | $98.9M | Sell |
729,859
-1,182,287
| -62% | -$157M | 0.58% | 44 |
|
|
2023
Q4 | $258M | Sell |
1,912,146
-1,117,631
| -37% | -$145M | 1.61% | 28 |
|
|
2023
Q3 | $410M | Hold |
3,029,777
| – | – | 2.32% | 16 |
|
|
2023
Q2 | $434M | Buy |
3,029,777
+96,000
| +3% | +$14.1M | 2.59% | 12 |
|
|
2023
Q1 | $407M | Sell |
2,933,777
-4,454
| -0.2% | -$599K | 2.47% | 12 |
|
|
2022
Q4 | $398M | Buy |
2,938,231
+145,750
| +5% | +$18.3M | 2.58% | 10 |
|
|
2022
Q3 | $306M | Buy |
2,792,481
+477,500
| +21% | +$60.6M | 1.87% | 15 |
|
|
2022
Q2 | $306M | Buy |
2,314,981
+526,889
| +29% | +$69.1M | 1.79% | 17 |
|
|
2022
Q1 | $237M | Buy |
1,788,092
+835,014
| +88% | +$100M | 1.31% | 32 |
|
|
2021
Q4 | $111M | Buy |
953,078
+786,078
| +471% | +$92.5M | 0.63% | 46 |
|
|
2021
Q3 | $20.1M | Buy |
+167,000
| New | +$19.4M | 0.11% | 101 |
|
|
2019
Q4 | – | Sell |
-1,187,893
| Closed | -$106M | – | 118 |
|
|
2019
Q3 | $106M | Sell |
1,187,893
-862,107
| -42% | -$74.8M | 0.87% | 31 |
|
|
2019
Q2 | $169M | Buy |
2,050,000
+107,500
| +6% | +$8.43M | 1.18% | 25 |
|
|
2019
Q1 | $157M | Hold |
1,942,500
| – | – | 1.3% | 27 |
|
|
2018
Q4 | $148M | Buy |
1,942,500
+232,500
| +14% | +$18.2M | 1.29% | 29 |
|
|
2018
Q3 | $135M | Sell |
1,710,000
-215,000
| -11% | -$16.3M | 0.95% | 31 |
|
|
2018
Q2 | $135M | Buy |
1,925,000
+142,500
| +8% | +$10.3M | 1% | 30 |
|
|
2018
Q1 | $125M | Sell |
1,782,500
-100,000
| -5% | -$6.93M | 1.04% | 33 |
|
|
2017
Q4 | $131M | Buy |
1,882,500
+292,500
| +18% | +$19.7M | 1.31% | 28 |
|
|
2017
Q3 | $108M | Buy |
1,590,000
+1,302,500
| +453% | +$82.3M | 1.12% | 28 |
|
|
2017
Q2 | $19.6M | Sell |
287,500
-288,750
| -50% | -$18.9M | 0.22% | 55 |
|
|
2017
Q1 | $35.9M | Buy |
576,250
+393,750
| +216% | +$22.9M | 0.44% | 43 |
|
|
2016
Q4 | $9.97M | Buy |
+182,500
| New | +$10.4M | 0.15% | 56 |
|
Other funds holding AZN
IA
VCM
VAM